Nanotechnology Drug Delivery Systems Market Worth USD 76.5 Billion by 2020, Research Study by iHealthcareAnalyst, Inc.

Maryland Heights, MO, September 30, 2016 --(PR.com)-- According to a market research report Nanotechnology Drug Delivery Systems Market 2013-2020, published by iHealthcareAnalyst, Inc., the global nanotechnology drug delivery systems market is estimated to reach USD 76.5 Billion in 2020, expanding at a CAGR of 10.6% from 2016 to 2020.

Visit the Nanotechnology Drug Delivery Systems Market 2013-2020 report at http://www.ihealthcareanalyst.com/report/nanotechnology-drug-delivery-systems-market/

The global nanotechnology drug delivery systems market segmentation is based on technology types (nanocrystals, nanoparticles, dendrimers, gold nanoparticles, fullerenes, liposomes, micelles, nanotubes), and its applications (anti-infective, anti-inflammatory, immunology, cardiovascular, physiology, neurology, oncology). The global nanotechnology drug delivery systems market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

Nanotechnology drug delivery systems involve the engineering of functional systems at the molecular scale, characterized by unique physical, optical and electronic features. Nanomedicine is a highly specific medical intervention for the prevention, diagnosis and treatment of diseases. Several anti-cancer drugs including paclitaxel, doxorubicin, 5-fluorouracil and dexamethasone have been successfully formulated using nanomaterials. Quantom dots, chitosan, Polylactic/glycolic acid (PLGA) and PLGA-based nanoparticles have also been used for in vitro RNAi delivery.

The global nanotechnology drug delivery systems market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global nanotechnology drug delivery systems market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

1. Technology
1.1. Nanocrystals
1.2. Nanoparticles
1.3. Dendrimers
1.4. Gold Nanoparticles
1.5. Fullerenes
1.6. Liposomes
1.7. Micelles
1.8. Nanotubes
1.9. Others

2. Application
2.1. Anti-infective
2.2. Anti-inflammatory/Immunology
2.3. Cardiovascular/Physiology
2.4. Neurology
2.5. Oncology
2.6. Others

3. Geography (Region, Country)
3.1. North America (U.S., Canada)
3.2. Latin America (Brazil, Mexico, Rest of LA)
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
3.4. Asia Pacific (Japan, China, India, Rest of APAC)
3.5. Rest of the World

4. Company Profiles
4.1. AbbVie, Inc.
4.2. Amgen Inc.
4.3. Celgene Corporation
4.4. Johnson & Johnson
4.5. Merck & Co., Inc.
4.6. Novartis International AG
4.7. Perrigo Company plc
4.8. Pfizer, Inc.
4.9. Teva Pharmaceutical Industries Ltd.

About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com